KEGG   DRUG: Dextroamphetamine
Entry
D03740                      Drug                                   
Name
Dextroamphetamine (USAN);
Dexamfetamine (INN);
Xelstrym (TN)
Product
Formula
C9H13N
Exact mass
135.1048
Mol weight
135.2062
Structure
Simcomp
Class
Neuropsychiatric agent
 DG03085  Selective norepinephrine reuptake inhibitor (NRI)
Metabolizing enzyme substrate
 DG01644  CYP2D6 substrate
Remark
Same as: C07884
ATC code: N06BA02
Chemical structure group: DG00967
Product (DG00967): D03740<US> D02078<US>
Efficacy
Stimulant (central)
  Disease
Attention deficit hyperactivity disorder [DS:H01895]
Comment
Compoment of Biphetamine (TN)
Target
SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]
SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
SLC6A3 (DAT1) [HSA:6531] [KO:K05036]
  Pathway
hsa04721  Synaptic vesicle cycle
hsa04726  Serotonergic synapse
hsa04728  Dopaminergic synapse
hsa05031  Amphetamine addiction
Metabolism
Enzyme: CYP2D6 [HSA:1565]
Interaction
Structure map
map07234  Neurotransmitter transporter inhibitors
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N06 PSYCHOANALEPTICS
   N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
    N06BA Centrally acting sympathomimetics
     N06BA02 Dexamfetamine
      D03740  Dextroamphetamine (USAN) <US>
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG03085  Selective norepinephrine reuptake inhibitor (NRI)
   DG00967  Dexamfetamine
    D03740  Dextroamphetamine
 Metabolizing enzyme substrate
  DG01644  CYP2D6 substrate
   DG00967  Dexamfetamine
    D03740  Dextroamphetamine
Target-based classification of drugs [BR:br08310]
 Transporters
  Solute carrier family
   SLC6
    SLC6A2 (NAT1)
     D03740  Dextroamphetamine (USAN) <US>
    SLC6A3 (DAT1)
     D03740  Dextroamphetamine (USAN) <US>
   SLC18
    SLC18A2 (VMAT2)
     D03740  Dextroamphetamine (USAN) <US>
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D03740
Prodrugs [br08324.html]
 D03740
Narcotics and psychotropics in Japan [br08308.html]
 Stimulants by Control Act Article 2 Appended Table and Cabinet Order
  D03740
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG03085  Selective norepinephrine reuptake inhibitor (NRI)
   DG00967  Dexamfetamine
 Metabolizing enzyme substrate
  DG01644  CYP2D6 substrate
   DG00967  Dexamfetamine
Other DBs
CAS: 51-64-9
PubChem: 17397829
ChEBI: 4469
PDB-CCD: 1WE[PDBj]
LigandBox: D03740
NIKKAJI: J4.121A
KCF data

ATOM        10
            1   C8y C    18.0875  -15.2739
            2   C8x C    16.8262  -14.5732
            3   C8x C    18.0875  -16.6754
            4   C1b C    19.2786  -14.5732
            5   C8x C    15.6350  -15.2739
            6   C8x C    16.8262  -17.3761
            7   C1c C    20.4698  -15.2739
            8   C8x C    15.6350  -16.6754
            9   N1a N    21.6609  -14.5732
            10  C1a C    20.4695  -16.6597
BOND        10
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 2
            8     7   9 1
            9     6   8 1
            10    7  10 1 #Up

» Japanese version   » Back

DBGET integrated database retrieval system